Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

635 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
Ties D, van Dorp P, Pundziute G, van der Aalst CM, Gratama JWC, Braam RL, Kuijpers D, Lubbers DD, van der Bilt IAC, Westenbrink BD, Wolcherink MJO, Doggen CJM, Išgum I, Nijveldt R, de Koning HJ, Vliegenthart R, Oudkerk M, van der Harst P. Ties D, et al. Among authors: van dorp p, van der aalst cm, van der harst p, van der bilt iac. Am Heart J. 2022 Apr;246:166-177. doi: 10.1016/j.ahj.2022.01.005. Epub 2022 Jan 14. Am Heart J. 2022. PMID: 35038412 Free article. Clinical Trial.
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van der meer p, van veldhuisen dj. Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17. Eur Heart J. 2007. PMID: 17576662
Can critically short telomeres cause functional exhaustion of progenitor cells in postinfarction heart failure?
Oeseburg H, Westenbrink BD, de Boer RA, van Gilst WH, van Veldhuisen DJ, van der Harst P. Oeseburg H, et al. Among authors: van gilst wh, van der harst p, van veldhuisen dj. J Am Coll Cardiol. 2007 Nov 6;50(19):1911-2; author reply 1912-3. doi: 10.1016/j.jacc.2007.07.055. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980263 Free article. No abstract available.
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Westenbrink BD, Oeseburg H, Kleijn L, van der Harst P, Belonje AM, Voors AA, Schoemaker RG, de Boer RA, van Veldhuisen DJ, van Gilst WH. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van veldhuisen dj. Cardiovasc Drugs Ther. 2008 Aug;22(4):265-74. doi: 10.1007/s10557-008-6094-y. Epub 2008 Mar 11. Cardiovasc Drugs Ther. 2008. PMID: 18327705
Bone marrow dysfunction in chronic heart failure patients.
Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P, Vellenga E, van Veldhuisen DJ, van Gilst WH. Westenbrink BD, et al. Among authors: van gilst wh, van der harst p, van veldhuisen dj. Eur J Heart Fail. 2010 Jul;12(7):676-84. doi: 10.1093/eurjhf/hfq061. Epub 2010 Apr 28. Eur J Heart Fail. 2010. PMID: 20427614 Free article.
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Among authors: van rossum ac, van der horst ic, van der horst schrivers an, van der harst p, van veldhuisen dj. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
Urinary and plasma magnesium and risk of ischemic heart disease.
Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJ, Navis G, Bakker SJ; PREVEND Study Group. Joosten MM, et al. Among authors: van der harst p. Am J Clin Nutr. 2013 Jun;97(6):1299-306. doi: 10.3945/ajcn.112.054114. Epub 2013 Mar 13. Am J Clin Nutr. 2013. PMID: 23485414 Free article.
635 results